Results 281 to 290 of about 219,582 (315)
Some of the next articles are maybe not open access.
Zebrafish ApoB-Containing Lipoprotein Metabolism: A Closer Look
Arteriosclerosis, Thrombosis, and Vascular BiologyZebrafish have become a powerful model of mammalian lipoprotein metabolism and lipid cell biology. Most key proteins involved in lipid metabolism, including cholesteryl ester transfer protein, are conserved in zebrafish. Consequently, zebrafish exhibit a human-like lipoprotein profile.
Tabea O.C. Moll, Steven A. Farber
openaire +2 more sources
Beneficial Effects of a Novel Thyromimetic on Lipoprotein Metabolism
Molecular Pharmacology, 1997Although L-triiodothyronine (L-T3) lowers cholesterol, this hormone is not used to treat hypercholesterolemia because of its cardiotoxic effects. Thyromimetics, such as the novel compound CGS 23425, that mimic the beneficial but lack the detrimental effects of T3, may be useful in the treatment of hypercholesterolemia.
A H, Taylor +3 more
openaire +2 more sources
High Density Lipoprotein Metabolism in a Patient with Abetalipoproteinemia
Annals of Nutrition and Metabolism, 1981The concentration of individual plasma apoproteins together with the in vivo metabolism of 125I-labelled high density lipoprotein was studied in an adult male patient with abetalipoproteinemia. Plasma concentrations of cholesterol (26 mg/dl) and triglyceride (5 mg/dl) were markedly reduced and apoprotein B was absent.
D R, Illingworth +2 more
openaire +2 more sources
Atherosclerosis, 2001
Lipoprotein(a) is a risk factor for cardiovascular disease composed of an apolipoprotein B-containing lipoprotein to which a second protein, apolipoprotein(a), is attached. We investigated in seven subjects with Lp(a) levels of 39--85 mg/dl the metabolism of four apo B-containing lipoproteins (VLDL(1), VLDL(2), IDL and LDL) together with that of apo B ...
T, Demant +3 more
openaire +2 more sources
Lipoprotein(a) is a risk factor for cardiovascular disease composed of an apolipoprotein B-containing lipoprotein to which a second protein, apolipoprotein(a), is attached. We investigated in seven subjects with Lp(a) levels of 39--85 mg/dl the metabolism of four apo B-containing lipoproteins (VLDL(1), VLDL(2), IDL and LDL) together with that of apo B ...
T, Demant +3 more
openaire +2 more sources
[Lipoprotein(a): structure, metabolism and atherosclerotic disease].
Minerva medica, 1993Lipoprotein(a) was discovered by chance by Berg in 1963; after twenty years of research, the chemical, physical and metabolic characteristics of Lp(a) are now known. This lipoprotein forms the missing link between the lipid metabolism and the coagulation-fibrinolysis process. The A. describe its similarity to plasminogen, its capacity to delay coagulum
G, Postorino, R, Altavilla
openaire +1 more source
Pediatric Lipoprotein Metabolism and Atherosclerosis: A Prospectus
1980The purpose here will be to summarize briefly the recent advances in the area of lipid and lipoprotein metabolism in pediatrics and, in view of the newer data, to discuss a number of questions that remain unanswered. A recurrent theme will be the relation of atherosclerosis to lipoprotein metabolism in early life, with an emphasis on identification of ...
openaire +1 more source
Nutrition Research, 2004
The classical lipoproteins have been extensively studied for their effects on the development of coronary artery disease and atherosclerosis in general. Although low-density and high-density lipoproteins are emphasized in determining risk and in devising treatment strategies, other less common lipoprotein classes have been identified that promote ...
openaire +1 more source
The classical lipoproteins have been extensively studied for their effects on the development of coronary artery disease and atherosclerosis in general. Although low-density and high-density lipoproteins are emphasized in determining risk and in devising treatment strategies, other less common lipoprotein classes have been identified that promote ...
openaire +1 more source
Metabolomics in cancer research and emerging applications in clinical oncology
Ca-A Cancer Journal for Clinicians, 2021Daniel R Schmidt +2 more
exaly
Genetic and Metabolic Determinants of Lipoprotein(a)
Journal of Clinical Lipidology, 2023Sarah L Stewart +17 more
openaire +1 more source
Lipoprotein metabolism in renal replacement therapy: a review.
Israel journal of medical sciences, 1996Lipoprotein disorders are considered an important cause for the high cardiovascular morbidity and mortality in patients with end-stage renal disease and following renal transplantation. This article reviews the disease-associated changes of lipids and lipoproteins in these patients and, where known, the underlying causes and mechanisms.
F, Kronenberg +3 more
openaire +1 more source